← The Wire
CNTANasdaq
Centessa Pharmaceuticals plc
Pharmaceutical Preparations · X0 · CIK 1847903
Centessa Pharmaceuticals plc pioneers orexin-based neuroscience therapeutics for wakefulness and mood disorders
red 8-K · 90d
$6.15B
Market cap
$40.50
Last close
+0.8%
1D
+1.9%
5D
11.3M
Volume
Price · last 35 sessions+2.0%
May 4L $39.58 · H $40.50Jun 23
123
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
SC 13D/ASC 13D/AJun 26, 20268-KDelisting Notice · Change of ControlJun 24, 2026SC 13DSC 13DJun 24, 20268-KShareholder Vote · Company UpdateJun 12, 20268-KCompany UpdateMay 22, 202610-Q10-QMay 5, 2026DEF 14ADEF 14AApr 29, 2026DEFA14ADEFA14AApr 13, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 202610-K10-KMar 31, 2026DEFA14ADEFA14AMar 31, 20268-KMaterial Agreement · Reg FD DisclosureMar 31, 20268-KExecutive ChangeFeb 13, 20268-K/AExecutive ChangeJan 7, 20268-KExecutive Change · Reg FD DisclosureDec 11, 20258-KCompany UpdateNov 24, 2025424B5424B5Nov 24, 20258-KMaterial Agreement · Company UpdateNov 13, 2025424B5424B5Nov 13, 2025424B5424B5Nov 12, 202510-Q10-QNov 5, 20258-KResults of Operations · Reg FD DisclosureNov 5, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KShareholder VoteJun 20, 20258-KCompany UpdateJun 17, 20258-KExecutive ChangeMay 29, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 28, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEF 14ADEFINITIVE PROXY STATEMENTMay 6, 202510-K10-KMar 24, 20258-KResults of OperationsMar 24, 20258-KMaterial AgreementFeb 21, 202510-Q/A10-Q/AFeb 14, 20258-KReg FD DisclosureJan 8, 20258-KMaterial Agreement · Agreement TerminatedDec 30, 202410-Q10-QNov 12, 20248-KResults of Operations · Reg FD DisclosureNov 12, 202410-Q/A10-Q/AOct 18, 2024424B5424B5Sep 13, 20248-KMaterial Agreement · Company UpdateSep 13, 2024424B5424B5Sep 11, 20248-KReg FD Disclosure · Company UpdateSep 10, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KShareholder VoteJun 25, 20248-KExecutive Change · Reg FD DisclosureJun 10, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 21, 202410-Q10-QMay 13, 20248-KResults of OperationsMay 13, 2024DEF 14ADEFINITIVE PROXY STATEMENTMay 9, 2024424B5424B5Apr 25, 20248-KMaterial Agreement · Results of OperationsApr 24, 2024424B5424B5Apr 23, 20248-KReg FD Disclosure · Company UpdateApr 22, 202410-K10-KMar 28, 20248-KResults of OperationsMar 28, 20248-KReg FD DisclosureFeb 9, 20248-KReg FD DisclosureJan 9, 20248-KReg FD DisclosureDec 11, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KReg FD Disclosure · Company UpdateOct 25, 20238-KCompany UpdateAug 24, 202310-Q10-QAug 14, 20238-KResults of Operations · Reg FD DisclosureAug 14, 20238-KReg FD Disclosure · Company UpdateJul 10, 20238-KShareholder VoteJun 22, 20238-KReg FD DisclosureJun 9, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 23, 20238-KReg FD Disclosure · Company UpdateMay 22, 2023DEF 14ADEFINITIVE PROXY STATEMENTMay 15, 202310-Q10-QMay 12, 20238-KResults of OperationsMay 12, 202310-K10-KMar 30, 20238-KResults of Operations · Reg FD DisclosureMar 30, 2023
Insider Activity
In the 90 days to Mar 26, 2026: 3 sold $13.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Anderson Karen M.Chief People Officer | Sell | 41,076 | $30.12 | $1.2M |
| Mar 26, 2026 | Weinhoff Gregory MChief Business Officer | Sell | 23,998 | $30.00 | $720K |
| Mar 17, 2026 | Anderson Karen M.Chief People Officer | Sell | 10,043 | $28.10 | $282K |
| Mar 16, 2026 | Anderson Karen M.Chief People Officer | Sell | 64,768 | $28.21 | $1.8M |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 107,961 | $26.15 | $2.8M |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 107,961 | $26.15 | $2.8M |
| Mar 13, 2026 | Weinhoff Gregory MChief Business Officer | Sell | 61,253 | $26.17 | $1.6M |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 12,068 | $27.13 | $327K |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 12,068 | $27.13 | $327K |
| Mar 13, 2026 | Weinhoff Gregory MChief Business Officer | Sell | 11,943 | $27.16 | $324K |
| Feb 2, 2026 | Hussain Iqbal JChief Legal Officer | Sell | 38,951 | $25.15 | $980K |
| Jan 30, 2026 | Hussain Iqbal JChief Legal Officer | Sell | 1,010 | $25.01 | $25K |
| Dec 9, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 7,432 | $28.70 | $213K |
| Dec 9, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 2,568 | $29.21 | $75K |
| Dec 8, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 10,000 | $30.00 | $300K |
| Nov 17, 2025 | Bush Tia LChief Technology & Quality Ofc | Sell | 40,000 | $28.00 | $1.1M |
| Nov 17, 2025 | Hussain Iqbal JGeneral Counsel | Sell | 6,000 | $27.64 | $166K |
| Nov 12, 2025 | Bush Tia LChief Technology & Quality Ofc | Sell | 40,000 | $26.00 | $1.0M |
| Oct 27, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 8,000 | $25.00 | $200K |
| Oct 15, 2025 | Hussain Iqbal JGeneral Counsel | Sell | 6,000 | $22.41 | $134K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance